Lincomycin Hydrochloride Anhydrous

HCID 64710

Basic information

CAS
859-18-7
Standard SMILES
CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1.Cl
InChIKey
POUMFISTNHIPTI-BOMBIWCESA-N
Molecular formula
C18H35ClN2O6S
Average molar mass
443 g/mol
Monoisotopic mass
442.19043552

Overview

Lincomycin Hydrochloride is the hydrochloride salt form of lincomycin, a lincosamide antibiotic originally identified in actinomycete Streptomyces lincolnensis with activity against gram-positive cocci and anaerobic bacteria.

Names & identifiers

Preferred name
Lincomycin Hydrochloride Anhydrous
IUPAC
(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;hydrochloride
English name
Lincomycin hydrochloride
Molecular formula
C18H35ClN2O6S
Molecular weight
443

Names & synonyms

Lincomycin hydrochloride859-18-7LINCOMYCIN HCLLincomix 20Lincomycin hydrochloride anhydrousLincomixDTXSID7047803GCW8Y9936LLincomycin solubleLincolnensin hydrochlorideDTXCID9027780Lincomycin hydrochloride anhdrous
Show more names
Lincomycin hydrochloride monohydrateLincomycin HCILincorexLintamycinMETHYL 6,8-DIDEOXY-6-(1-METHYL-4-PROPYL-2-PYRROLIDINECARBOXAMIDO)-1-THIO-D-ERYTHRO-ALPHA-D-GALACTOOCTOPYRANOSIDE HYDROCHLORIDE(2S,4R)-N-((1R,2R)-2-Hydroxy-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2H-pyran-2-yl)propyl)-1-methyl-4-propylpyrrolidine-2-carboxamide hydrochlorideLizpionU-10149ALincogap
D-erythro-alpha-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, monohydrochloride, (2S-trans)-NSC70731NSC-70731NSC-757092Linco SolubleLinxMed-SPLincomix 50LincoBac 300

Database identifiers

CAS
859-18-7
PubChem CID
64710
DTXSID
DTXSID7047803
ChEMBL
CHEMBL3989551
UNII
GCW8Y9936L
EC Number
212-726-7

Properties

Computed structural properties

Topological polar surface area
148 Ų
Hydrogen bond donors
6
Hydrogen bond acceptors
8
Rotatable bonds
7
Heavy atoms
28

Experimental & physicochemical properties

Human Drugs · 2 items

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Animal DrugsActive Ingredients (Lincomycin Hydrochloride) -> FDA Greenbook
Collision Cross Section199.1 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physicochemical properties

Melting point
156 · 156-158C
storage temp.
2 · 2-8°C
solubility
2 O: · H2O: 50 mg/mL, clear, colorless
form
solid
color
white to white with yellow cast
Water Solubility
Soluble in water.

Safety & regulation

GHS classification

GHS Classification · 4 items

Warning

H315 (62.2%): Causes skin irritation [Warning Skin corrosion/irritation]

P261, P264, P264+P265, P271, P272, P273, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P333+P317, P337+P317, P362+P364, P391, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 82 reports by companies from 13 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Regulatory Information · 2 items

Status: Active Update: 17-03-2022 https://echa.europa.eu/registration-dossier/-/registered-dossier/33514

lincomycin hydrochloride: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.

Other Safety InformationIMAP assessments - D-erythro-.alpha.-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-, monohydrochloride, (2S-trans)-: Environment tier I assessment
Hazard Classes and CategoriesSkin Irrit. 2 (62.2%)

Toxicology

Drug Induced Liver Injury · 6 items

Drug Induced Liver Injury Rank (DILIrank 2.0)

Lincomycin hydrochloride

Ambiguous-DILI-concern

3

Warnings & precautions

DOI:10.1016/j.drudis.2016.02.015

Safety data

F
10
PPE
dust mask type N95 (US), Eyeshields, Gloves
wgk
2
rtecs
RH6315000
hs_code
29419000
risk_code
36/37/38-20/21/22

Chemistry & industry

Pharmacology

MeSH Pharmacological Classification · 2 items

Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins.

Substances that inhibit the growth or reproduction of BACTERIA.

Uses & manufacturing

Use ClassificationAnimal Drugs -> FDA Approved Animal Drug Products (Green Book) -> Active Ingredients
Applications · 4 items

UsesAn antibiotic produced by Streptomyces lincolnensis. Lincomycin is a lincosamide antibiotic that forms cross-links within the peptidyl transferase loop region of the 23S rRNA. Inhibits bacterial protein synthesis. Antibacterial.

UsesAntibacterial;Ribosomal protein synthesis inhibitor

UsesLincomycin hydrochloride is a salt of lincomycin formed at the basic N-methylproline. The hydrochloride salt is the preferred formulation for pharmaceutical use. Lincomycin hydrochloride is a broad spectrum antibiotic with activity against anaerobic bacteria and protozoans. Lincomycin acts by binding to the 23S ribosomal subunit, blocking protein synthesis. Lincomycin has been extensively studied with over 7,000 literature citations.

General DescriptionChemical structure: macrolide

Upstream & downstream products

Upstream raw materials

Suppliers100 total

北京华美互利生物化工010-56205725 · [email protected]
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
上海如吉生物科技发展有限公司+86-21-65211385-8001 36031160 · [email protected]
广州隽唐科技有限公司020-36607679 13502246435 · [email protected]
LGM Pharma1-(800)-881-8210 · [email protected]

Related reactions

1 records

Compound notes

Loading…